---
tags:
  - BCGuidelines
---

## BC Guidelines: Rheumatoid Arthritis - Diagnosis, Management and Monitoring

**Resource:** [https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/rheumatoid-arthritis](https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/rheumatoid-arthritis)

Comprehensive BC clinical guideline for early recognition, intervention, diagnosis, management, and monitoring of adults with rheumatoid arthritis, aligned with [Canadian Rheumatology Association](https://rheum.ca/) and international standards.

### Early Recognition & Diagnosis
- **Early RA Definition**: Symptoms <3 months; early intervention prevents permanent joint damage
- **Clinical Features**: Morning stiffness >30 min, painful swelling of 3+ joints, symmetrical hand/foot involvement, symptoms â‰¥4 weeks
- **Laboratory**: CRP/ESR for inflammation; RF and Anti-CCP for diagnosis/prognosis (seropositive RA has worse prognosis)
- **Imaging**: Early x-rays may be normal; serial imaging monitors progression
- **Early Specialist Referral**: Should not be delayed for lab confirmation when clinical features present

### Management
- **DMARDs**: Early initiation (methotrexate, sulfasalazine, hydroxychloroquine); combination therapy for some patients
- **Biologics**: Specialist use for poor responders to non-biologic DMARDs
- **Symptom Control**: NSAIDs/corticosteroids for flares (not long-term)
- **Multidisciplinary Care**: Physiotherapy, occupational therapy, coordinated regular reviews
- **Patient Self-Management**: Disease education, medication adherence, exercise, joint protection, lifestyle (smoking cessation, healthy diet)

### Monitoring
- **Regular Clinical Review**: Disease activity, radiographic progression, treatment toxicity, comorbid conditions (cardiovascular risk is doubled in RA)
- **Laboratory Monitoring**: CRP/ESR to guide treatment; routine bloodwork for DMARD side effects
- **Imaging**: Repeat x-rays as indicated for progression
- **Long-Term Surveillance**: Periodic liver, renal, hematological monitoring with DMARD therapy

### Additional Resources
- [Full practitioner guideline](https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/rheumatoid_arthritis.pdf) and [quick reference summary](https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/ra_guideline_summary.pdf) PDFs
- [Patient information guide](https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/rheumatoid_arthritis_pg.pdf)
- Alignment with [CRA living guidelines](https://rheum.ca/resources/publications/) and [ACR recommendations](https://www.rheumatology.org/)